If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

ENTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,921,460.24

Enanta Pharmaceuticals Insider Trading History Chart

Enanta Pharmaceuticals Share Price & Price History

^$40.28

▲ +1.07 (2.73%)

As of 03/31/2023 12:23 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Enanta Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2023	Paul J Mellett	CFO	Sell	10,440	$44.43	$463,849.20	97,556
3/15/2023	Yat Sun Or	VP	Sell	13,925	$44.45	$618,966.25	374,702
3/13/2023	Jay R. Luly	CEO	Sell	27,912	$45.16	$1,260,505.92	819,810
2/9/2023	Paul J Mellett	CFO	Sell	5,000	$53.76	$268,800.00	83,463
12/16/2022	Jay R. Luly	CEO	Sell	30,000	$44.72	$1,341,600.00	773,805
4/4/2022	Nathalie Adda	VP	Sell	32,785	$72.18	$2,366,421.30	34,982
4/1/2022	Nathalie Adda	VP	Sell	50,559	$71.23	$3,601,317.57	34,982
3/21/2022	Bruce L A Carter	Director	Sell	6,000	$67.83	$406,980.00
3/1/2022	Nathalie Adda	VP	Sell	24,339	$70.26	$1,710,058.14
1/11/2022	Nathalie Adda	VP	Sell	12,536	$70.13	$879,149.68
12/1/2021	Nathalie Adda	VP	Sell	13,523	$86.35	$1,167,711.05
11/1/2021	Nathalie Adda	VP	Sell	9,547	$84.89	$810,444.83
10/11/2021	Nathalie Adda	VP	Sell	4,047	$70.34	$284,665.98
10/8/2021	Nathalie Adda	VP	Sell	13,453	$70.09	$942,920.77
9/15/2021	Jay R. Luly	CEO	Sell	4,516	$59.06	$266,714.96
1/8/2021	Paul J Mellett	CFO	Sell	6,000	$45.58	$273,480.00	61,759

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Enanta Pharmaceuticals (NASDAQ:ENTA)

93.68% of Enanta Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enanta Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/23/2023	ETF Managers Group LLC	5,185	$0.24M	0.0%	-15.2%	0.025%
2/22/2023	Teachers Retirement System of The State of Kentucky	5,998	$0.28M	0.0%	+38.2%	0.029%
2/16/2023	Alliancebernstein L.P.	22,415	$1.04M	0.0%	-56.1%	0.107%
2/15/2023	Public Employees Retirement System of Ohio	25,864	$1.20M	0.0%	-18.5%	0.124%
2/15/2023	State of Tennessee Treasury Department	13,142	$0.61M	0.0%	+3.0%	0.063%
2/15/2023	Kiwi Wealth Investments Limited Partnership	8,380	$0.39M	0.0%	N/A	0.040%
2/15/2023	State of Wisconsin Investment Board	18,755	$0.87M	0.0%	-6.1%	0.090%
2/15/2023	Soleus Capital Management L.P.	137,814	$6.41M	0.9%	+12.0%	0.660%
2/15/2023	Squarepoint Ops LLC	13,818	$0.64M	0.0%	+165.1%	0.066%
2/15/2023	Tang Capital Management LLC	200,000	$9.30M	1.4%	+45.2%	0.958%
2/15/2023	Legal & General Group Plc	56,382	$2.62M	0.0%	+2.6%	0.270%
2/15/2023	Millennium Management LLC	56,083	$2.61M	0.0%	+49.2%	0.269%
2/15/2023	Morgan Stanley	138,525	$6.44M	0.0%	-23.8%	0.663%
2/15/2023	Man Group plc	13,698	$0.64M	0.0%	N/A	0.066%
2/15/2023	Norges Bank	226,419	$10.53M	0.0%	N/A	1.084%
2/15/2023	Algert Global LLC	16,480	$0.77M	0.0%	-29.9%	0.079%
2/15/2023	Alps Advisors Inc.	14,079	$0.66M	0.0%	+24.8%	0.067%
2/15/2023	AQR Capital Management LLC	17,227	$0.80M	0.0%	+77.3%	0.082%
2/15/2023	Armistice Capital LLC	2,078,000	$96.67M	1.7%	+0.3%	9.949%
2/15/2023	Braidwell LP	325,838	$15.16M	0.5%	N/A	1.560%
2/14/2023	Price T Rowe Associates Inc. MD	174,303	$8.11M	0.0%	-27.6%	0.835%
2/14/2023	Two Sigma Investments LP	32,114	$1.49M	0.0%	+126.3%	0.154%
2/13/2023	Charles Schwab Investment Management Inc.	145,890	$6.79M	0.0%	+2.7%	0.698%
2/13/2023	Deutsche Bank AG	10,738	$0.50M	0.0%	+25.8%	0.051%
2/13/2023	Wells Fargo & Company MN	816	$38K	0.0%	-56.2%	0.004%
2/13/2023	Barclays PLC	50,899	$2.37M	0.0%	+12.2%	0.244%
2/13/2023	Renaissance Technologies LLC	473,200	$22.01M	0.0%	+1.1%	2.265%
2/13/2023	Credit Suisse AG	28,470	$1.32M	0.0%	+2.5%	0.136%
2/13/2023	Martingale Asset Management L P	20,863	$0.97M	0.0%	+21.6%	0.100%
2/13/2023	Geode Capital Management LLC	378,941	$17.63M	0.0%	+4.4%	1.814%
2/13/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	20,850	$0.97M	0.0%	+17.5%	0.100%
2/13/2023	GSA Capital Partners LLP	11,057	$0.51M	0.1%	N/A	0.053%
2/13/2023	JPMorgan Chase & Co.	181,539	$8.45M	0.0%	+5.2%	0.869%
2/13/2023	Cornercap Investment Counsel Inc.	5,742	$0.27M	0.0%	N/A	0.027%
2/13/2023	Teacher Retirement System of Texas	5,969	$0.28M	0.0%	-7.4%	0.029%
2/10/2023	Bank of America Corp DE	55,277	$2.57M	0.0%	+25.9%	0.265%
2/10/2023	Victory Capital Management Inc.	4,120	$0.22M	0.0%	-76.2%	0.020%
2/10/2023	Franklin Resources Inc.	5,025	$0.23M	0.0%	-15.9%	0.024%
2/9/2023	Victory Capital Management Inc.	4,120	$0.22M	0.0%	-76.2%	0.020%
2/9/2023	Dimensional Fund Advisors LP	543,566	$25.29M	0.0%	+6.6%	2.603%
2/9/2023	Principal Financial Group Inc.	122,398	$5.69M	0.0%	-4.0%	0.586%
2/9/2023	Citigroup Inc.	48,560	$2.26M	0.0%	-30.8%	0.232%
2/8/2023	UBS Group AG	38,016	$1.77M	0.0%	+1,645.5%	0.182%
2/8/2023	Skandinaviska Enskilda Banken AB publ	18,338	$0.85M	0.0%	-5.5%	0.088%
2/8/2023	Swiss National Bank	47,500	$2.21M	0.0%	+1.7%	0.227%
2/8/2023	Russell Investments Group Ltd.	24,583	$1.14M	0.0%	+15.3%	0.118%
2/8/2023	Arizona State Retirement System	5,555	$0.26M	0.0%	+3.9%	0.027%
2/7/2023	Texas Permanent School Fund	13,097	$0.61M	0.0%	-6.6%	0.063%
2/7/2023	Shell Asset Management Co.	4,904	$0.23M	0.0%	-17.4%	0.023%
2/6/2023	Banque Pictet & Cie SA	16,851	$0.78M	0.0%	-24.0%	0.081%
2/2/2023	SG Americas Securities LLC	19,248	$0.90M	0.0%	+128.2%	0.092%
2/2/2023	ProShare Advisors LLC	4,808	$0.22M	0.0%	+8.4%	0.023%
1/26/2023	Comerica Bank	10,732	$0.52M	0.0%	-23.8%	0.051%
1/26/2023	Inspire Investing LLC	5,137	$0.24M	0.0%	+28.9%	0.025%
1/23/2023	Allspring Global Investments Holdings LLC	3,472	$0.16M	0.0%	-37.3%	0.017%
1/12/2023	Hennion & Walsh Asset Management Inc.	31,329	$1.46M	0.1%	-55.5%	0.151%
1/12/2023	Assenagon Asset Management S.A.	52,411	$2.44M	0.0%	+127.3%	0.252%
1/9/2023	Yousif Capital Management LLC	11,589	$0.54M	0.0%	-22.7%	0.056%
12/8/2022	Bank of New York Mellon Corp	174,179	$9.04M	0.0%	+3.8%	0.837%
11/22/2022	Teachers Retirement System of The State of Kentucky	4,341	$0.23M	0.0%	N/A	0.021%
11/21/2022	California State Teachers Retirement System	24,666	$1.28M	0.0%	-1.3%	0.119%
11/16/2022	BNP Paribas Arbitrage SNC	26,361	$1.37M	0.0%	+325.0%	0.127%
11/15/2022	Alliancebernstein L.P.	51,029	$2.65M	0.0%	-59.6%	0.246%
11/15/2022	State Street Corp	1,377,417	$71.45M	0.0%	-18.9%	6.646%
11/15/2022	Public Employees Retirement System of Ohio	31,735	$1.65M	0.0%	+388.4%	0.153%
11/15/2022	Jacobs Levy Equity Management Inc.	352,303	$18.27M	0.1%	+18.4%	1.700%
11/15/2022	Algert Global LLC	23,510	$1.22M	0.1%	-19.0%	0.113%
11/15/2022	Thrivent Financial for Lutherans	20,138	$1.05M	0.0%	+11.2%	0.097%
11/15/2022	Two Sigma Advisers LP	46,700	$2.42M	0.0%	-18.9%	0.225%
11/15/2022	Two Sigma Investments LP	14,192	$0.74M	0.0%	+4.4%	0.068%
11/15/2022	Trexquant Investment LP	4,882	$0.25M	0.0%	-21.9%	0.024%
11/15/2022	Vanguard Group Inc.	1,476,910	$76.61M	0.0%	-2.6%	7.126%
11/15/2022	Price T Rowe Associates Inc. MD	240,687	$12.49M	0.0%	+27.8%	1.161%
11/15/2022	Putnam Investments LLC	32,002	$1.66M	0.0%	-25.6%	0.154%
11/15/2022	Martingale Asset Management L P	17,157	$0.89M	0.0%	+9.2%	0.083%
11/15/2022	ETF Managers Group LLC	6,116	$0.32M	0.0%	-6.5%	0.030%
11/15/2022	Ensign Peak Advisors Inc	35,270	$1.83M	0.0%	+3.5%	0.170%
11/15/2022	First Manhattan Co.	243,718	$12.64M	0.1%	+7.0%	1.176%
11/15/2022	Bank of New York Mellon Corp	174,179	$9.04M	0.0%	+3.8%	0.840%
11/15/2022	BlackRock Inc.	3,621,795	$187.86M	0.0%	+2.9%	17.471%
11/15/2022	Commodore Capital LP	103,494	$5.37M	0.9%	N/A	0.499%
11/14/2022	AlphaCrest Capital Management LLC	10,700	$0.56M	0.0%	N/A	0.052%
11/14/2022	Armistice Capital LLC	2,072,000	$107.48M	1.9%	+0.1%	9.998%
11/14/2022	Tudor Investment Corp Et Al	10,327	$0.54M	0.0%	-13.8%	0.050%
11/14/2022	Point72 Hong Kong Ltd	2,169	$0.11M	0.0%	+38.6%	0.010%
11/14/2022	Cubist Systematic Strategies LLC	40,323	$2.09M	0.0%	+7.7%	0.195%
11/14/2022	Renaissance Technologies LLC	468,000	$24.28M	0.0%	-13.8%	2.258%
11/14/2022	Nuveen Asset Management LLC	70,475	$3.66M	0.0%	-2.1%	0.340%
11/14/2022	AXA S.A.	6,200	$0.32M	0.0%	N/A	0.030%
11/14/2022	MetLife Investment Management LLC	10,340	$0.54M	0.0%	-5.6%	0.050%
11/14/2022	Shell Asset Management Co.	5,939	$0.31M	0.0%	-20.7%	0.029%
11/14/2022	Hsbc Holdings PLC	5,742	$0.30M	0.0%	-71.2%	0.028%
11/14/2022	E Fund Management Co. Ltd.	4,381	$0.23M	0.0%	-30.7%	0.021%
11/14/2022	Pictet Asset Management SA	54,097	$2.81M	0.0%	+82.6%	0.261%
11/14/2022	Hennion & Walsh Asset Management Inc.	70,324	$3.65M	0.2%	-9.2%	0.339%
11/10/2022	Credit Suisse AG	27,768	$1.44M	0.0%	+16.1%	0.134%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	5,110	$0.27M	0.0%	N/A	0.025%
11/10/2022	ExodusPoint Capital Management LP	12,804	$0.66M	0.0%	N/A	0.062%
11/10/2022	Dimensional Fund Advisors LP	509,878	$26.45M	0.0%	-2.6%	2.460%
11/10/2022	Tower Research Capital LLC TRC	6,145	$0.32M	0.0%	-49.7%	0.030%

Data available starting January 2016

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Today's Range

Now: $40.28

$39.14

$40.47

50 Day Range

MA: $47.69

$38.82

$54.59

52 Week Range

Now: $40.28

$37.59

$79.50

Volume

12,568 shs

Average Volume

171,394 shs

Market Capitalization

$841.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Enanta Pharmaceuticals?: Enanta Pharmaceuticals' top insider shareholders include:
Jay R Luly (CEO)
Yat Sun Or (VP)
Paul J Mellett (CFO)
Nathalie Adda (VP)
Bruce L A Carter (Director)
Learn More about top insider investors at Enanta Pharmaceuticals.
Who are the major institutional investors of Enanta Pharmaceuticals?: Enanta Pharmaceuticals' top institutional investors include:
Armistice Capital LLC — 9.95%
Dimensional Fund Advisors LP — 2.60%
Renaissance Technologies LLC — 2.27%
Geode Capital Management LLC — 1.81%
Braidwell LP — 1.56%
Norges Bank — 1.08%
Learn More about top institutional investors of Enanta Pharmaceuticals stock.
Which major investors are selling Enanta Pharmaceuticals stock?: During the last quarter, ENTA stock was sold by these institutional investors:
Price T Rowe Associates Inc. MD
Morgan Stanley
Hennion & Walsh Asset Management Inc.
Alliancebernstein L.P.
Citigroup Inc.
Victory Capital Management Inc.
Victory Capital Management Inc.
Algert Global LLC
In the last year, company insiders that have sold Enanta Pharmaceuticals company stock include:
Jay R Luly (CEO)
Yat Sun Or (VP)
Paul J Mellett (CFO)
Nathalie Adda (VP)
Learn More investors selling Enanta Pharmaceuticals stock.
Which major investors are buying Enanta Pharmaceuticals stock?: During the previous quarter, ENTA stock was bought by institutional investors including:
Braidwell LP
Norges Bank
Tang Capital Management LLC
UBS Group AG
Dimensional Fund Advisors LP
Assenagon Asset Management S.A.
Millennium Management LLC
Two Sigma Investments LP

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

ENTA Insider Trading

Enanta Pharmaceuticals Insider Trading History Chart

Enanta Pharmaceuticals Share Price & Price History

Enanta Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Enanta Pharmaceuticals (NASDAQ:ENTA)

Institutional Buying and Selling by Quarter

Enanta Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Enanta Pharmaceuticals?

Who are the major institutional investors of Enanta Pharmaceuticals?

Which major investors are selling Enanta Pharmaceuticals stock?

Which major investors are buying Enanta Pharmaceuticals stock?